E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability

33Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

E3 ubiquitin ligase RNF126 (ring finger protein 126) is highly expressed in various cancers and strongly associated with tumorigenesis. However, its specific function in bladder cancer (BCa) is still debatable. Here, we found that RNF126 was significantly upregulated in BCa tissue by TCGA database, and our studies indicated that downregulation of RNF126 significantly inhibited cell proliferation and metastasis through the EGFR/PI3K/AKT signaling pathway in BCa cells. Furthermore, we identified PTEN, an inhibitor of the PI3K/AKT signaling pathway, as a novel substrate for RNF126. By co-immunoprecipitation assays, we proved that RNF126 directly interacts with PTEN. Predominantly, PTEN binds to the C-terminal containing the RING domain of RNF126. The in vivo ubiquitination assay showed that RNF126 specifically regulates PTEN stability through poly-ubiquitination. Furthermore, PTEN knockdown restored cell proliferation, metastasis, and tumor formation of BCa cells inhibited by RNF126 silencing in vitro and in vivo. In conclusion, these results identified RNF126 as an oncogene that functions through ubiquitination and degradation of PTEN in BCa.

Cite

CITATION STYLE

APA

Xu, H., Ju, L., Xiong, Y., Yu, M., Zhou, F., Qian, K., … Wang, X. (2021). E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death and Disease, 12(3). https://doi.org/10.1038/s41419-021-03521-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free